Lv53
1092 积分 2024-07-22 加入
Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy
2小时前
求助中
Prospective Randomized Trial of Docetaxel Versus Doxorubicin in Patients With Metastatic Breast Cancer
2小时前
待确认
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study
3小时前
已关闭
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial
3小时前
待确认
Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel
6小时前
已关闭
Significantly Longer Progression-Free Survival With nab-Paclitaxel Compared With Docetaxel As First-Line Therapy for Metastatic Breast Cancer
6小时前
待确认
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
7小时前
待确认
Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials
7小时前
待确认
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
1天前
待确认
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
2天前
已完结
皖公网安备34019202002308
